Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis - Wikidata - wikimedia - TriplyDB

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

http://www.wikidata.org/entity/Q35071318

about

Preventing deaths due to the hypertensive disorders of pregnancy Could EEG Monitoring in Critically Ill Children Be a Cost-effective Neuroprotective Strategy?Pre-eclampsia: an update.Antenatal Exposure to Magnesium Sulfate Is Associated with Reduced Cerebellar Hemorrhage in Preterm Newborns Economic evaluation and cost of interventions for cerebral palsy: a systematic review.

P2860

Q28075616-F190209C-3A86-4E2C-A927-50D80A4D1156 Q30685457-47011822-B30F-4D86-A367-E833A1345F9E Q38219228-1EEB7BCF-58E9-4D3D-B1E4-213549B2EC26 Q40480909-F03781AA-2589-493E-96D9-D501A750B2CC Q47566061-D13C9585-67AE-4662-8060-5B5B5B499E5F

P2860

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

http://www.wikidata.org/entity/Q35071318

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@ast

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@en

type

label

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@ast

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@en

prefLabel

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@ast

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@en

P1433

Q35071318-18E069A2-2A3F-4873-89B6-9C5D95908648

P1476

Q35071318-953108CE-611C-4401-A382-93551169A8AE

P2093

Q35071318-04670444-ABDC-424A-9E31-24D8B9CC722A

Q35071318-1D44C518-1820-4A96-BDE9-BF581B16DAA3

Q35071318-3B0E2E74-CD13-4E4B-A69C-F4F9EEE51C98

Q35071318-4CE2C618-D17E-4EF6-9AF6-B9C407422D42

Q35071318-C1D9F017-9565-407A-A4E8-007D06F75D1F

Q35071318-C8D1F83B-071A-4FDD-AFB6-29B6936BAEB5

Q35071318-ECDE9C7B-B6CE-491E-8519-144CB41EA112

Q35071318-FB78977A-6DAF-42BD-8B96-4E361C01A701

P2860

Q35071318-16594984-94D4-4CB9-8005-AC66663DF833

Q35071318-30D5A6F6-9E70-4678-A29B-7EF1BD771FA9

Q35071318-313FBF1B-357D-4881-BD0E-2EE40A5F1494

Q35071318-36AA64F4-4311-4558-96D2-3DC2CD5E4765

Q35071318-65245D59-35FB-4F26-B298-5BACC5590AA6

Q35071318-665A2516-92C3-4CA3-A410-68949F6AA6EB

Q35071318-685768C8-A8F8-4579-9DF9-2A18CB6C8E04

Q35071318-69D70ED4-EEC4-4D91-9E71-72047C729DFA

Q35071318-707C849F-BFCF-48A2-8863-68FE0268B2F5

Q35071318-75E477B3-921F-485D-86B3-CC0D7F593F0F

P2888

Q35071318-9C133628-D80B-430D-9DD4-54D1E5AE53C5

P304

Q35071318-ED2ED921-AC20-4197-9923-5E3D73BAA1AB

P31

Q35071318-B8942FD5-6BFE-4D18-81C6-C52E9BC24049

P356

Q35071318-E2F26EA6-2F79-4A3C-95AC-7037F7CA7604

P478

Q35071318-12792708-8C7B-44A3-AD6D-2ED190EC8645

P50

Q35071318-06005AE0-B816-4018-8CE5-438E4E432FCB

Q35071318-CAC52E8E-2887-4581-B7D6-4DEFA72C2EC2

P577

Q35071318-B0D9175B-C27A-4B53-8B99-2CD630A58A70

P5875

Q35071318-63BC9722-D2FC-4413-BD53-E1E7A34514B7

P6179

Q35071318-DAD9B646-EF16-4067-A1B5-990A3AAF5121

P698

Q35071318-CD3605C9-EE22-406C-9DA2-20E90403BB09

P932

Q35071318-AA6E54F0-F830-4A5D-9308-9AF2E5121404

P356

1472-6963-13-527

P1433

BMC Health Services Research

P1476

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

@en

P2093

Anne R Synnes

http://www.w3.org/2001/XMLSchema#string

Celeste D Bickford

http://www.w3.org/2001/XMLSchema#string

Craig Mitton

http://www.w3.org/2001/XMLSchema#string

Diane Sawchuck

http://www.w3.org/2001/XMLSchema#string

Laura A Magee

http://www.w3.org/2001/XMLSchema#string

MAG-CP Working Group

http://www.w3.org/2001/XMLSchema#string

Melanie Basso

http://www.w3.org/2001/XMLSchema#string

Vyta M Senikas

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment with magnesium sulphate in pre-term birth: A systematic review and meta-analysis of observational studies

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus

The Health Utilities Index (HUI): concepts, measurement properties and applications

SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.

Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

Life expectancy in severe cerebral palsy.

Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.

US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.

Association of cord blood magnesium concentration and neonatal resuscitation.

P2888

1472-6963-13-527

P304

527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6963-13-527

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Peter von Dadelszen

P577

2013-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259385717

http://www.w3.org/2001/XMLSchema#string

P6179

1028419189

http://www.w3.org/2001/XMLSchema#string

P698

24350635

http://www.w3.org/2001/XMLSchema#string

P932

3878233

http://www.w3.org/2001/XMLSchema#string